SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
XP Inc. (XPVVV) trades at a trailing P/E of 4.5. Trailing earnings yield is 22.08%. PEG 0.25 (Peter Lynch undervalued ≤1.0).
Criteria proven by this page:
- VALUE (100/100, Pass) — P/E is below market average (4.5); PEG ≤ 1.0 — Peter Lynch undervalued (0.25); earnings yield beats bond yields (22.08%).
- PEG Ratio 0.25 — below 1.0 suggests the stock is undervalued relative to its earnings growth rate (Peter Lynch criterion).
- Trailing Earnings Yield 22.08% — exceeds typical bond yields (~4.3%), making equity attractive vs fixed income.
Overall SharesGrow Score: 77/100 with 4/7 criteria passed.
SharesGrow 7-Criteria Score
✓
VALUE
100/100
Price-to-Earnings & upside
Proven by this page
✗
HEALTH
33/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — XPVVV
Valuation Multiples
P/E (TTM)4.5
Forward P/EN/A
PEG Ratio0.25
Forward PEGN/A
P/B Ratio0.00
P/S Ratio1.28
EV/EBITDA0.0
Per Share Data
EPS (TTM)$9.72
Book Value / Share$0.00
Revenue / Share$34.29
FCF / Share$0.00
Yields & Fair Value
Earnings Yield22.08%
Dividend Yield0.00%
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2016 |
$0.44 |
$689.88M |
$243.77M |
35.3% |
| 2017 |
$0.75 |
$1.28B |
$413.87M |
32.2% |
| 2018 |
$0.84 |
$2.05B |
$461.44M |
22.5% |
| 2019 |
$2.11 |
$3.6B |
$1.08B |
30% |
| 2020 |
$3.71 |
$5.02B |
$2.08B |
41.4% |
| 2021 |
$6.26 |
$6.2B |
$3.59B |
57.9% |
| 2022 |
$6.25 |
$5.94B |
$3.58B |
60.2% |
| 2023 |
$7.16 |
$6.53B |
$3.9B |
59.7% |
| 2024 |
$8.23 |
$7.42B |
$4.51B |
60.8% |
| 2025 |
$9.72 |
$18.24B |
$5.07B |
27.8% |
